No Data
Yuekang Pharmaceutical: Report for the first quarter of 2025
2025 First Quarter Report
Youcare Pharmaceutical Group (688658.SH) reported a net loss of 49.2711 million yuan in the first quarter.
On April 28, Gelonghui reported that Youcare Pharmaceutical Group (688658.SH) announced its first quarter report for 2025, achieving revenue of 0.577 billion yuan, a year-on-year decrease of 40.35%; the net income attributable to shareholders of the listed company was -49.2711 million yuan; the basic EPS was -0.11 yuan.
Institutions Along With Private Companies Who Hold Considerable Shares InYoucare Pharmaceutical Group Co., Ltd. (SHSE:688658) Come Under Pressure; Lose 13% of Holdings Value
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
2024 ANNUAL REPORT
Some Confidence Is Lacking In Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658) As Shares Slide 26%
